Newsroom

COSTA MESA, Kalifornien--(BUSINESS WIRE)--Experian wurde von Foundry’s CIO für seine Transformation der Arbeitsumgebung in Unternehmen gewürdigt, bei der künstliche Intelligenz und moderne digitale Tools integriert werden, um die Produktivität und Entscheidungsfindung seiner weltweiten Belegschaft zu verbessern, und wurde dafür als ein Gewinner des 2026 CIO 100 Award ausgezeichnet. Seit mehr als 40 Jahren werden mit den CIO 100 Awards Unternehmen ausgezeichnet, die durch technologische Führungs...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 16.04.2026 FEUD IE00BF2FL590 367,749.00 EUR 20,349,158.48 55.334  ...

カリフォルニア州コスタメサ--(BUSINESS WIRE)--（ビジネスワイヤ） -- エクスペリアンは、2026 CIO 100 Awardを受賞しました。これは、人工知能と最新のデジタルツールを統合し、世界中の従業員の生産性と意思決定の向上を図る同社のエンタープライズ向けワークプレース変革が評価され、FoundryのCIOより2026 CIO 100 Award受賞企業に選出されました。 CIO 100 Awardsは40年以上にわたり、テクノロジーリーダーシップを通じてビジネス価値を創出する企業を表彰してきました。 CIO 100 Awards and Conferenceのイベントコンテンツ責任者であるリチャード・スミスは、次のように述べました。「今年表彰する組織は、単に業務を維持しているだけではなく、ビジネス成果の創出を積極的に主導しています。人工知能、データ、セキュリティ、クラウドの機能は、いまや一つの明確なリーダーシップのビジョンの下で融合しています。今年の受賞企業は、それらの要素が十分に連動したときに何が可能になるかを示しています。」 AI対応ワークフォースを支える...

LAGUNA HILLS, Calif. & BILLERICA, Mass.--(BUSINESS WIRE)--PreludeDx® and Quanterix Corporation (Nasdaq: QTRX) today highlighted that AidaBREAST™, the first multi-omic assay to predict both locoregional recurrence risk and radiation therapy benefit in early-stage invasive breast cancer, was developed on Akoya PhenoImager® HT platform using Opal™ chemistry. This marks a significant milestone in the clinical translation of spatial proteomics. The validation of AidaBREAST included 922 hormone recep...

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on April 16, 2026, the company granted restricted stock units (RSUs) with respect to 4,253 shares of the company’s common stock to four newly hired employees. These grants were made pursuant to the company’s 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of the board of directors pursuant to a delegation by the company’s board of directors, and were made as a material inducement t...

MONTPELIER, Vt.--(BUSINESS WIRE)--Alex “AD” David, President and CEO of Equity Services, Inc., the broker-dealer and registered investment adviser affiliated with National Life Group, has been named one of five industry leaders recognized in the Wealth Solutions Report Pathfinder Awards. The Pathfinder Awards recognize executives from underrepresented backgrounds who are making a meaningful impact across wealth management through leadership, innovation, and influence. David is one of five indus...

LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare services platform in Latin America with operations in Mexico, Peru, and Colombia, today reported select operating metrics for the First Quarter ended March 31, 2026. The Company intends to publish these key performance indicators on a quarterly basis going forward, as part of its commitment to providing investors with more information and a clearer understanding of Auna. Preliminary Key Performan...

MILWAUKEE--(BUSINESS WIRE)--Badger Meter, Inc. (NYSE: BMI) today reported results for the first quarter ended March 31, 2026. First Quarter 2026 Highlights Total sales of $202.3 million, 9% lower than the prior year’s $222.2 million. Operating earnings of $35.2 million, with an operating profit margin of 17.4%, compared to operating earnings of $49.4 million and an operating margin of 22.2% in the prior year. Diluted earnings per share (EPS) of $0.93, down from $1.30 in the first quarter of 202...

DALLAS--(BUSINESS WIRE)--Sieve Capital LLC (collectively with its affiliates, “Sieve” or “we”), a shareholder of Americold Realty Trust, Inc. (“Americold” or the “Company”), today issued the following open letter urging shareholders to vote “AGAINST” the reelection of Mark Patterson and Andrew Power to the Company’s Board of Directors (the “Board”) at Americold’s upcoming Annual Meeting of Shareholders (the “Annual Meeting”). Of note, Messrs. Patterson and Power currently serve together as dire...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that all required regulatory approvals have been obtained for its previously announced acquisition of Arcellx and that Gilead has extended the expiration of the tender offer to purchase all outstanding shares of common stock of Arcellx. On April 13, 2026, the Australian Competition and Consumer Commission (ACCC) published its decision that the acquisition of Arcellx may be put into effect, subject to expi...